Here, you’ll find information about preparing research-based oral and performance presentations. Oral presentations are often supplemented by some sort of slideshow (e.g., one created in Microsoft PowerPoint), because people tend to understand and retain what they both hear and see. Performance presentations and film/exhibit/demonstrations are broadly defined and include dance/music/theatre performances, fine art exhibitions, product/device demonstrations, and other similar creative products.
https://www.youtube.com/watch?v=LzIJFD-ddoI&feature=youtu.be
UURAF 2025 will be a hybrid event consisting of oral, poster, performance, film and exhibit presentations. UURAF is a public event. Do not share confidential information in your abstract or presentation.
Presenters can expect to interact with judges and visitors through the chat function and dedicated discussion sessions on the event platform Symposium by ForagerOne. Please respond promptly to questions.
Due to space limitations, oral presentations will only be offered as a virtual option.
Online Only
Anna Goins; Cheryl Rauh; Danielle Tarner; and Daniel Von Holten
Learning Objectives
In the workplace, many writing projects are partnered with presentations, which translate documents into easily accessible information for a live audience.
Some common scenarios for workplace presentations can include:
In the workplace, you may often have to adapt information into an effective presentation to share with others in situations like these and more.
Each presentation situation is unique. Start by utilizing the same strategies for analyzing and planning for writing mentioned in introduction . Then, before you begin outlining your presentation’s structure and content, consider the following constraints specific to presentations:
Once you have considered the presentation’s audience, you can begin planning your presentation by answering the following questions:
Once you’ve identified your purpose and defined your audiences, you can identify the type of presentation you need to give and what strategies to employ. Typically, a presentation will employ elements of more than one of the types listed below.
Informative presentations might involve simply reporting information or explaining concepts, applications, or methods to your audience. A presentation on annual sales numbers and scenarios 1 and 3 listed above both fall into this category.
This type of presentation could be meant to influence the audience’s point of view or convince the audience to follow a particular course of action. Typically, this will involve presenting evidence and logical arguments in addition to engaging your audience. A proposal could be a type of persuasive presentation as could any sales related presentation like scenario 4 listed above.
These types of presentations frequently show up at special events like weddings, award ceremonies, and even funerals, and are generally performed as a speech with little to no visual aid. The purpose is to generate goodwill and basically have a positive impact on the audience’s emotional state. In a professional setting, you may have to give a talk at a special event like an employee of the year celebration or celebrations of special events related to your company or the company’s location. Something like scenario 2 could be likely if your company invests in community relations. They differ from other presentations that they frequently serve a ceremonial or even ritual-like role in their setting.
It could be argued that there are as many formats for presentations as there are presentations, but we will look at a few general formats to get some ideas on how you might form your presentation.
This format is probably what you envision when you think of a formal presentation or speech—the presenter talks while the audience is silent. There typically isn’t dialog between the speaker and audience. The only communication between them may be non-verbal. An advantage of this style is that it is easy to execute once you’ve prepared for it. A disadvantage is that it may leave an audience with unanswered questions.
This approach is often, but not always, less formal and allows for greater interaction with the audience. While the presenter may spend some time presenting information or an argument, much of the time is focused on responding to questions from the audience. A town-hall-style talk or a sales meeting with a small group of clients might take this form. This format can create a strong sense of engagement with the audience, but preparing for it is more challenging as the presenter needs to be able to adapt to questions, but also keep the presentation on topic.
Group presentations will typically use features of the formats listed above, but may differ in how the group members relate to each other.
Group members give parts of one integrated presentation. Members may take turns speaking or split topics of the presentation between them. They may act out scenarios together at points if that is the most effective means of communicating their concept. The key here is that despite having several presenters, there is a clear sense that it is all one presentation. This type of presentation takes a lot of coordination and practice between group members to be effective.
You may see something like this as a panel talk at a professional or academic conference. Each group member gives an individual presentation, but each presentation relates to the others.
An effective presentation will be easy to absorb and remember. When reading, a person can stop, pause, and reread if they didn’t catch a point the first time. Unfortunately, unless a presentation is being recorded and made accessible online, if the listener misses something, there’s no way to go back and catch it again. As a result, adapting your writing into a memorable presentation requires distilling your content into a more focused verbal presentation. From there, the keys to helping your audience remember your most important points are repetition and emphasis.
As in writing, you want to include transitions to guide your audience in following your structure. Transitions will not only guide your audience, but are an example of using repetition and emphasis to help your audience retain the key points of your presentation. Plan on including one or two sentences much like you do in writing to transition between the opening, body, major points within the body, and your presentation’s close. For example, in a presentation discussing ways to retain employees within your company you could include a transition between your first and second main points. In this example, a transition could be something like, “Before we look at several key strategies for retaining employees, let’s take a moment to review the major causes of employee separation from our company.”
Now, let’s look at strategies for structuring and organizing the opening, body, and close of your presentation.
One of the best ways to assure your audience members take note of what’s important in your presentation is to catch their attention quickly and set up clear expectations for what they can expect to learn. Consider choosing from some of the following strategies:
This section is where you will address and develop the main points of your topic. As a result, this section will take up most of the time allotted for your presentation.
It is important to end a presentation as strongly as you began. Audiences tend to remember the opening and closing of a presentation, so avoid rushing through this section; ultimately, your ending provides an opportunity to once again emphasize and repeat your key points.
Visuals are a great way to support your verbal points in a presentation. So what makes an effective presentation visual?
When creating slides or other visual tools, plan to spend about approximately 1-2 minutes on each visual or slide. Lastly, you may want to review and adapt the principles of effective design .
Our best advice for successfully delivering presentations is to practice using any technology you intend to use in your talk.
Chapter 8: Oral Reports Copyright © by Anna Goins; Cheryl Rauh; Danielle Tarner; and Daniel Von Holten is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License , except where otherwise noted.
Oral report guidelines, introduction.
All advanced lab students must present one of the first three labs as an oral report. The fourth and final lab cannot be an oral report. You are free to select which of the first three reports you will submit as an oral report. E ach student needs to give an individual report and the analysis needs to be your own. The dates, times, and locations will be posted approximately the week before oral reports are due, and you must sign up in advance. Use the online spreadsheet to select a time and place for your exam with one of the course professors. If you don’t show up at your sign-up time, you will receive 0 point for the oral report. Ten points will be deducted for every ten-minute lateness.
The time allotted for an oral report is 60 minutes. You should plan to talk for about 30-40 minutes with time for questions. Expect your professor to ask questions during the talk and after the report. The exam will end after an hour, so plan your time carefully and focus on the important concepts.
An oral report is a form of show-and-tell. The purpose is to give you experience in presenting the contents of an experiment in a manner understandable to one of your classmates, someone who has taken the same courses, studied the same topics, but who has not yet done the experiment.
The exams this semester are being given via Zoom. You will want to use an presentation software such as Powerpoint or Keynote to prepare and present your report. The report should show that you did something, that you understand what you did, and that you are familiar enough with the experiment to answer questions that your classmates might ask. You are expected to present the necessary diagrams and the useful equations as you speak. You need to present your results along with their uncertainties. The atmosphere is informal and you may use your notes, but do not read your report. It helps to practice your talk ahead of time, with an audience if possible. Do not assume that the listener has read over the laboratory information sheets. You can’t possibly tell everything you know, so pick and choose carefully what to include and what to leave out. Start at a low level, and build up to the essentials of the subject. You are telling a story. Make it coherent and interesting. We want to see how you think about physics. It will not be the same as the way we would put things – don’t copy anyone else, either student or faculty. It’s your talk. Tell it like it is, as you see it. Below is a suggested order in which to tell the story, but it is certainly not the only way.
It pays to practice, and if you still feel uncomfortable after practicing, ask a GSI to help you by listening to your talk and offering suggestions. You may even go so far as to ask some one to coach you. We are here to help you learn, we want everyone’s report to be outstanding.
Both the University and the 111 Lab staff take the subject of plagiarism very seriously. Please make sure you understand completely the following and ask questions if ever in doubt:
"All data that you present in your reports must be your own. All written work that you submit, except for acknowledged quotations, is to be in your own words. Figures from books, papers, or online sources are fine so long as the source is cited. Work copied from another student's report, or from any other source without attribution, under University rules, earn the student a grade of 'F' for the semester , and possible disciplinary action by the Student Conduct Committee."
In some classes, writing the research paper is only part of what is required. Your professor may also require you to give an oral presentation about your study. Here are some things to think about before you are scheduled to give your presentation.
Creating and Using Overheads . Writing@CSU. Colorado State University; Giving an Oral Presentation. Academic Skills Centre. University of Canberra; Lucas, Stephen. The Art of Public Speaking. 10th ed. Boston, MA: McGraw-Hill Higher Education, 2008; Peery, Angela B. Creating Effective Presentations: Staff Development with Impact. Lanham, MD: Rowman and Littlefield Education, 2011; Peoples, Deborah Carter. Guidelines for Oral Presentations . Ohio Wesleyan University Libraries; Perret, Nellie. Oral Presentations . The Lab Report. University College Writing Centre. University of Toronto; Speeches . The Writing Center. University of North Carolina; Storz, Carl et al. Oral Presentation Skills . Institut national de télécommunications, EVRY FRANCE.
First of all, think about what you want to achieve and think about how are you going to involve your audience in the presentation.
GENERAL OUTLINE
I. Introduction (may be written last)
II. The Body
III. The Conclusion
Creating and Using Overheads . Writing@CSU. Colorado State University; Giving an Oral Presentation. Academic Skills Centre. University of Canberra; Lucas, Stephen. The Art of Public Speaking. 10th ed. Boston, MA: McGraw-Hill Higher Education, 2008; Peery, Angela B. Creating Effective Presentations: Staff Development with Impact. Lanham, MD: Rowman and Littlefield Education, 2011; Peoples, Deborah Carter. Guidelines for Oral Presentations . Ohio Wesleyan University Libraries; Perret, Nellie. Oral Presentations . The Lab Report. University College Writing Centre. University of Toronto; Speeches . The Writing Center. University of North Carolina; Storz, Carl et al. Oral Presentation Skills. Institut national de télécommunications, EVRY FRANCE.
Pay attention to language!
Use your voice to communicate clearly
Use your body language to communicate too!
Interact with the audience
Your First Words are Your Most Important!
Your introduction should begin with something that grabs the attention of your audience, such as, an interesting statisitic, a brief narrative or story, or a bold assertion, and then clearly tell the audience in a well-crafted sentence what you plan to accomplish in your presentation. Your introductory statement should be constructed so as to invite the audience to pay close attention to your message and to give the audience a clear sense of the direction in which you are about to take them.
Talk to Your Audience, Don't Read to Them!
A presentation is not the same as an essay. If you read your presentation as if it were an essay, your audience will probably understand very little about you say and will lose concentration quickly. Use notes, cue cards, or overheads as prompts that emphasis key points, and speak to the audience. Include everyone by looking at them and maintaining regular eye-contact (but don't stare or glare at people).
FIND US ON
Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy , ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.
Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.
One of the key concepts in education, along with teaching and learning, is assessment. Assessment is a method of finding out whether a student has understood and integrated the instructional material, and it can take a wide variety of forms. A school assessment might be a written report, a multimedia project, a group presentation, a classroom quiz or test, a standardized assessment, or an oral report.
An oral report is a presentation, usually done for a student’s teacher and classmates, though it can also be done for a larger segment of the school community, for parents, or for a more open group, depending on the circumstances. For example, at a science fair, a student might present a report on his or her project periodically for the class, for other visitors who pass by, and for judges.
A spoken report may have a variety of elements including an introduction, body, and conclusion. Audio-visual aids — such as posters, slides, movies, models, or other demonstrations — may be allowed or required. A question-and-answer session in which the student giving the presentation interacts with his or her audience may also be part of the expected proceedings.
An oral report is an opportunity for students to practice their speaking skills, but other skills may come into play as well. There are presentation skills, such as making eye contact with the audience, listening skills of a question and answer session, and the skill of anticipating how to present something in a way that will be understandable as well as appealing to the particular audience.
Although the report is oral, writing is often involved in its preparation — and sometimes the actual performance — of the presentation. A student may begin by creating a rough draft of what he or she will say and try reading it. The next step might be preparing either notes on a topic or an outline of points.
In preparing for an oral report, a student’s approach will vary somewhat depending on whether it must be delivered without notes. If the report has to be memorized, more practice will likely be required. If the student may speak from note cards or an outline — two popular methods for prompting one’s own performance — the preparation may focus more on other aspects of the presentation. Practice will also be shaped by how strict a time limit the student has been given: preparing a presentation to fall within a range is easier than trying to meet an exact length.
Our latest articles, guides, and more, delivered daily.
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
ESSAY — Volume 19 — September 8, 2022
Suggested citation for this article: Weintraub JA. The Oral Health in America Report: A Public Health Research Perspective. Prev Chronic Dis 2022;19:220067. DOI: http://dx.doi.org/10.5888/pcd19.220067 .
PEER REVIEWED
Data needed, health disparities and social determinants of health, individual and community relationships, scientific advances and equitable distribution, educational opportunities, acknowledgments, author information.
In December 2021, the National Institutes of Health, National Institute of Dental and Craniofacial Research, released its landmark 790-page report, Oral Health in America: Advances and Challenges (1). This is the first publication of its kind since the agency’s first Oral Health in America: A Report of the Surgeon General described the silent epidemic of oral diseases in 2000 (2). This new, in-depth report, an outstanding resource, had more than 400 expert contributors. Its broad scope is exemplified by its 6 sections ( Box ), each of which includes 4 chapters: 1) Status of Knowledge, Practice, and Perspectives; 2) Advances and Challenges; 3) Promising New Directions; and 4) Summary. In this essay, I provide a public health research perspective for viewing the report, identify some advances and gaps in our knowledge, and raise research questions for future consideration.
1. Effect of Oral Health on the Community, Overall Well-Being, and the Economy
2A. Oral Health Across the Lifespan: Children
2B. Oral Health Across the Lifespan: Adolescents
3A. Oral Health Across the Lifespan: Working-Age Adults
3B. Oral Health Across the Lifespan: Older Adults
4. Oral Health Workforce, Education, Practice, and Integration
5. Pain, Mental Illness, Substance Use, and Oral Health
6. Emerging Science and Promising Technologies to Transform Oral Health
A recurring theme in the report is the need for many types of data, from microdata — the molecular, nanoparticle level — to macrodata — the population and global level. Data are needed to guide public health policies and programs at the federal, state, and local levels. Future research using big data from multiple sources (eg, community health needs assessments, surveillance systems, GIS mapping, electronic health records, practice-based research networks) will provide timely, population-based information to evaluate and drive changes to policy and delivery systems and oral health advocacy efforts.
This new report includes descriptive national data from 3 cycles of the National Health and Nutrition Examination Survey (NHANES). To continue monitoring national oral health surveillance data and trends, oral health data need to be included routinely in NHANES and in other large national studies. Too often, questions about oral health are missing from surveys, or clinical oral health data are not collected. For example, very little about oral health was included as part of the planned data collection protocol for the National Institutes of Health All of Us Research Program. This program aims to collect health information from 1 million people (3). Local and state data are often outdated, incomplete, or unavailable. Most oral health data are cross-sectional and are useful for studying trends and associations, but population-based longitudinal data to study causality and the effectiveness of interventions and policies are sparse.
How does oral health care improve other health conditions? Proprietary claims data from insurance companies (4) show the inter-relationship between treatment of periodontal disease and systemic conditions, but secondary data analysis has many limitations and confounding factors. Clinical trials show that periodontal treatment improves glycemic control among people with diabetes (5), but long-term outcome assessments are lacking. We need more answers to convince policy makers and payers about the importance of including comprehensive adult oral health services in publicly financed programs such as Medicaid, which is currently lacking in many states, and Medicare, where those services are missing altogether.
Many examples of substantial oral health disparities and inequities are presented in Section 1 of the report. For some conditions and population groups, little improvement has been made, especially among adults and seniors. Section 1 also describes the adverse social, economic, and national security effects of poor oral health, barriers to care, social and commercial determinants of oral health, and related common risk factors. More than the clinical data collected in a typical dental history is needed to understand social determinants and employ local and upstream interventions. The report suggests obtaining social histories from patients to get information about where people live, learn, work, and play. For example, to learn about socioeconomic status, diet, and medications, we want to know not only “What’s in your wallet,” (as touted in a frequent television advertisement) but what’s in your refrigerator? What’s in your medicine cabinet? Telehealth has given clinicians a look inside patients’ homes. Collaboration with social workers, home health aides, and visiting nurses could inform us even more about the home environment. With integrated electronic medical and dental patient records, oral health professionals and medical colleagues can share information. Barriers to integration and assessment of population health outcomes affect many dentists who still use paper records or software specific to dental care that lacks diagnostic codes and interoperability with other health care records systems (6).
The report highlights the need for more information about adolescents and older adults and other understudied population groups. Section 1 describes many diverse, vulnerable populations (eg, people with special health care needs, low health literacy, mental illness, substance abuse disorders; victims of structural racism) who all need to be included in oral health research. Non-English speakers and hard-to-reach populations that have physical and/or financial barriers to traditional dental care are less likely to be recruited and represented in clinical trials, making results less generalizable and interventions less applicable. The applied research agenda being developed by the American Association of Public Health Dentistry (7) and the “Consensus Statement on Future Directions for the Behavioral and Social Sciences in Oral Health,” which is based on an international summit (8), are helpful in setting research and methodologic priorities, including qualitative, implementation, and health systems research.
Knowledge about the interrelationships between oral and systemic health has greatly expanded since the 2000 report. About 60 adverse health conditions have now been shown to be associated with oral health (1), which is part of the rationale for the integration of oral health and primary care. Research will advance our understanding of the mechanisms by which oral and systemic conditions are affected by upstream environmental and social factors, epigenetic factors, and the aging process, both individually and communally. For example, how do external exposures change our microbiomes? Our oral microbiome may be exposed to air containing Sars-CoV-2, water containing protective fluoride, or many kinds of food, beverages, medications, illicit substances, smoked products, and sometimes the biome of close personal contacts. How does the health of a community’s high caries risk groups change with policies such as a tax on sugar-sweetened beverages, Medicaid reimbursement changes, or health promotion efforts to improve oral health literacy and dietary behaviors? To what extent will increased application of value-based health care reimbursement with emphasis on disease prevention, early detection, and minimally invasive care improve oral health? Will the World Health Organization’s addition of dental products (eg, fluoride toothpaste, low-cost silver diamine fluoride, glass ionomer cement) to its Model List of Essential Medicines (9) increase their use to prevent and treat dental caries for under-resourced populations without access to conventional high-cost dental care?
The report’s Section 6 describes many exciting advances in biology, biomimetic dental materials, and technology. Rapid advances in salivary diagnostics are providing information about early, abnormal changes in remote organ systems in the body. Advanced imaging techniques and artificial intelligence can be used for early diagnosis of oral lesions before they are visible to the human eye. The validity and accuracy of these techniques need careful evaluation. Can these earlier clinical end points be used to shorten the length of expensive clinical trials? Guide new preventive strategies? At what point do providers intervene with early preventive or therapeutic strategies instead of letting the body heal itself?
Will populations at greatest risk for disease and the greatest barriers to accessing dental care be able to benefit from early intervention? Every intervention has a cost. If access to new prevention and therapeutic discoveries is not equitable, will health disparities worsen? We need community engagement in the research process and the tools from many disciplines to measure and facilitate the best outcomes. The national Oral Health Progress and Equity Network’s blueprint for improving oral health for all includes 5 levers to advance oral health equity: “amplify consumer voices, advance oral health policy, integrate dental and medical [care], emphasize prevention and bring care to the people” (10).
Who will analyze all these data mined from many micro and macro sources, and who will interpret the data? Health learning systems and complex software algorithms are being developed to provide automated diagnostic information. Data analysts with knowledge of these and other sophisticated tools and modeling approaches are needed.
The dental, oral, and craniofacial research and practice communities increasingly need to be part of interdisciplinary research and educational programs with opportunities for collaboration and learning. Federally qualified health centers and look-alikes are good sites for medical–dental integration, but many of these facilities do not provide dental care.
More positions are needed for dental public health specialists who can lead advocacy efforts, interdisciplinary teams of researchers, clinicians, and community partners and conduct research. For example, the new Dental Public Health Research Fellowship at the National Institute of Dental and Craniofacial Research will provide more intensive research training to further advance dental public health and population-based research. Mechanisms are needed to promote, facilitate, and reward sharing of research and training resources across disciplines in our competitive environment.
Public health perspectives are an important part of interdisciplinary approaches to guide, conduct, and apply research and implement policies to improve oral health. Preventive approaches exist as do barriers to their dissemination and implementation. To prevent disease and improve population oral and overall health, systems change and policy reform are needed along with scientific advances across the research spectrum, more population-level data and analysis, and community participatory engagement. I am optimistic that the next Oral Health in America report will describe fewer inequities and more progress toward oral health for all.
This article is based on a presentation made in the webinar, Oral Health in America — Advances and Challenges: Reading the Report through a Research Lens , sponsored by the American Association for Dental, Oral, and Craniofacial Research. The author received no financial support for this work and has no conflicts of interest to declare. The statements made are those of the author. No copyrighted materials were used in this article.
Corresponding Author: Jane A. Weintraub, DDS, MPH, R. Gary Rozier and Chester W. Douglass Distinguished Professor, University of North Carolina at Chapel Hill Adams School of Dentistry, Department of Pediatric and Public Health, Koury Oral Health Sciences Building, Suite 4508, Chapel Hill, NC 27599-7450. Telephone: (919) 537-3240. Email: [email protected] .
Author Affiliations: 1 University of North Carolina at Chapel Hill Adams School of Dentistry and Gillings School of Global Public Health, Chapel Hill, North Carolina.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
An official website of the United States government
Here’s how you know
Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Oral Health in America: Advances and Challenges is a culmination of two years of research and writing by over 400 contributors. As a follow up to the Surgeon General's Report on Oral Health in America, this report explores the nation's oral health over the last 20 years.
NIDCR has published corrections to the original report.
View the Notice Here
Scientific and technological advances present opportunities to improve the oral health of individuals and communities. These discoveries can drive new approaches for person-centered oral health care and help guide decision making by researchers, policy makers, clinicians, and individuals.
View Section 6 Snapshot
Effect of Oral Health on the Community, Overall Well-Being, and the Economy
View Section 1 Snapshot
Read Section 1 of the Report
Download the fact sheet (PDF - 304 KB)
Oral Health Across the Lifespan: Children
View Section 2A Snapshot
Read Section 2A of the Report
Download the fact sheet (PDF - 288 KB)
Oral Health Across the Lifespan: Adolescents
View Section 2B Snapshot
Read Section 2B of the Report
Download the fact sheet (PDF - 289 KB)
Oral Health Across the Lifespan: Working-Age Adults
View Section 3A Snapshot
Read Section 3A of the Report
Download the fact sheet (PDF - 300 KB)
Oral Health Across the Lifespan: Older Adults
View Section 3B Snapshot
Read Section 3B of the Report
Download the fact sheet (PDF - 301 KB)
Oral Health Workforce, Education, Practice, and Integration
View Section 4 Snapshot
Read Section 4 of the Report
Full Report (790 pages, 24.7 MB)
Download PDF
Executive Summary (28 Pages, 1.8 MB)
Errata Notice (2 pages, 238 KB)
Questions about the report? Email [email protected] or call 1-866-232-4528 .
A message from dr. rena d'souza.
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Scientific Reports volume 14 , Article number: 20802 ( 2024 ) Cite this article
Metrics details
Currently, surgical resection remains the primary approach for treating oral squamous cell carcinoma (OSCC), with limited options for effective drug therapy. Cardamonin, a principal compound derived from Myristica fragrans of the Zingiberaceae family, has garnered attention for its potential to suppress the onset and progression of various malignancies encompassing breast cancer, hepatocellular carcinoma, and ovarian cancers. Nevertheless, the involvement of cardamonin in the treatment of OSCC and its underlying mechanisms are yet to be elucidated. This research explored the possible target of cardamonin in treating OSCC via network pharmacological analysis. Subsequently, this research investigated the impact of cardamonin on OSCC cells via in vitro experiments, revealing its capacity to impede the migration, proliferation, and invasion of OSCC cells. Additionally, western blotting analysis demonstrated that cardamonin facilitates apoptosis by regulating the PI3K/AKT pathway. The findings suggest that MMP9 and the PI3K/AKT signaling pathway may serve as the target and pathway of cardamonin in treating OSCC. To summarize, the research findings suggest that cardamonin may facilitate apoptosis in OSCC cells by inhibition of PI3K/AKT pathway activation. These outcomes offer a theoretical basis for the utilization of cardamonin as a natural drug for treating OSCC.
Oral squamous cell carcinoma (OSCC) stands as the predominant type of head and neck tumors, comprising around 90% of oral malignant tumors 1 . Key contributors to its onset include tobacco, alcohol, and human papillomavirus (HPV) infections. Presently, surgical resection remains the primary treatment modality for OSCC, often complemented by postoperative chemoradiotherapy 2 . However, the 5-year survival rate remains dismally below 50%, exhibiting minimal improvement 3 .
In recent years, Chinese herbs have emerged as pivotal players in tumor treatment, serving as integral adjuncts to conventional therapies. Notably, certain chemotherapeutic agents, such as paclitaxel, vincristine 4 , and vinblastine 5 , derived from natural plant extracts, are extensively utilized in clinical settings. Cardamonin, a primary bioactive compound extracted from the ginger plant Myristica fragrans , exhibits a potent inhibitory effect on NF-kB 6 , STAT3, mTOR 7 , and Wnt/β-catenin signaling pathways 8 , all of which are widely involved in pro-inflammatory and pro-tumorigenic pathways. Consequently, cardamonin has been documented to exhibit antitumor 9 , anti-inflammatory 10 , and analgesic 11 impacts, alongside immunomodulatory properties and enhancement of chemotherapy response rates. Increased research has showcased the capability of cardamonin to promote tumor cell apoptosis and suppress cell migration and invasion across several cancer types, encompassing breast cancer 12 , hepatocellular carcinoma 13 , colorectal carcinoma 14 , and oesophageal carcinoma 15 , thereby inhibiting tumor growth and metastasis. Nevertheless, research on the role of cardamonin in OSCC remains limited, with its underlying mechanism remaining elusive. Considering the simple surgical approach for OSCC and the potential side effects associated with conventional drug therapies, there is an urgent need to explore natural chemotherapy agents.
The inception of network pharmacology as a concept can be attributed to Andrew L. Hopkins in 2007, a period that coincided with significant strides in bioinformatics and systems biology 16 . This approach is grounded in systems biology, aiming to construct a multilevel network encompassing genetic-disease and disease-disease interactions. Its primary objective is to elucidate the relationships between active medicinal components and diseases 17 . In addition, molecular docking, a computer-aided drug design method, enables the prediction of potential ligand–protein bindings by analyzing the structural characteristics of substances 18 . This study advocates for an integrated approach that integrates molecular docking, network pharmacology, and experimental methods to analyze potential targets. PI3K/Akt pathway transmits extracellular signals into cells to regulate various pathologic processes, such as cell metabolism, proliferation, It plays a key role in migration, apoptosis, vesicle transport, canceration and chemotherapy resistance 19 , 20 . The interaction between PI3K and Akt. It is the key core of the function of this pathway 21 . MMPs are a family of zinc-dependent, calcium-regulated endogenous proteases. It is usually produced in its precursor form (pro-MMPs), is activated by other enzymes or free radicals through cysteine switching mechanism 22 , and participates in extracellular matrix remodeling under normal physiological and pathological conditions 23 , promotes the transformation of various extracellular matrix proteins, plays an important role in the process of tissue remodeling, and leads to structural changes in the cellular and tissue environment. MMP-9, also known as gelatinase B, is often considered to be consistent with MMP-2 as a marker of tumor progression and is closely associated with tumor invasion and metastasis. MMP-9 degrades extracellular matrix, activates interleukin-1β, and dissolves and cuts several chemokines 24 . The comprehensive scheme of the research is depicted in Fig. 1 .
Research overview.
Acquisition of cardamonin targets.
The SMILES structural formula of cardamonin was retrieved from the PubChem database ( https://pubchem.ncbi.nlm.nih.gov/ ) 25 and subsequently imported into the Swiss Target Prediction database ( http://www.swisstargetprediction.ch/ ) 26 to identify potential targets of cardamonin.
Using "Oral squamous cell carcinoma" as the keyword in both the Gene Card ( https://www.genecards.org/ ) 27 and OMIM database ( https://www.omim.org/ ), disease-related targets were obtained. Duplicate targets identified in both databases were subsequently removed to isolate targets specifically related to OSCC. Following this, all identified targets associated with OSCC were imported into the online mapping tool ( http://www.bioinformatics.com.cn/static/others/jvenn/example.html ) to generate Venn diagram, thereby identifying intersectant targets between drugs and diseases.
The intersecting targets of drugs and diseases were imported into the String database ( https://string-db.org/cgi/input.pl ), with "Homo Sapiens" specified as the species for analysis. The confidence parameter was set to 0.4, and unassociated target proteins were removed. Subsequently, the Cytoscape 3.9.1 software was utilized to generate PPI network diagrams. Cytoscape is a sophisticated network analysis platform renowned for its robust data integration and visualization functions 28 . Core targets were obtained using the Centiscape2.2 plug-in acquisition.
The identified possible targets underwent Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) functional enrichment analyses utilizing the DAVID database. The species was set as "Homo sapiens," with a statistical significance threshold set at P < 0.01. Subsequently, GO function and KEGG pathway enrichment analysis, along with visualization of the findings, were conducted utilizing the Microbiotics online tool ( http://www.bioinformatics.com.cn/ ).
Molecular docking is a method of predicting the preferred direction of a molecule (ligand) when it binds to another molecule (receptor, such as RNA or enzyme). In this study, we adopted a semi-flexible docking method to form a stable composite. This process is critical for explaining mechanisms of action or screening lead compounds, and thus becomes one of the fundamental approaches for structure-based drug design. AutoDock Vina 1.1.2 software was used to combine cardamonin (PubChem CID: 641785) with proteins MMP9 (PDB ID: 1L6J), EGFR (PDB ID: 6TFV), ESR1 (PDB ID: 1HCQ), HSP90AB1 (PDB ID: 6N8Y), PPARG (PDB ID: 1PRG) and PTGS2 (PDB ID: 5F19) were used for molecular docking. 3D models of the proteins can be downloaded from the RCSB Protein Data Bank ( http://www.rcsb.org/pdb ). The protein was pre-treated with PyMol 2.4 (removing water molecules and excess ligands, adding hydrogen atoms). AutoDock Tools 1.5.6 is used to generate PDBQT files for docking simulation. Set the docking result to output the 10 best docking positions. The docking conformation with the lowest binding energy and the highest clustering frequency is considered to be the most potential binding mode between ligands and proteins. Finally, we used Pymol 2.0 software to visualize the docking results. In this way, we can visually observe the binding of the ligand to the receptor and further analyze the stability and interaction of the complex.
Cardamonin (purity > 95%) was procured from Solarbio (Beijing, China) and dissolved in DMSO (Dimethyl sulfoxide) ( Beijing , Solarbio ) to reach a concentration of 200 µmol/l. In the process of preparing the protein sample, Protein Phosphatase Inhibitor (P1260-1 ml, Beijing Solarbio) and PMSF (Phenylmethylsulfonyl fluoride) (P0100-1 ml, Beijing, Solarbio) were included. The following antibodies were utilized: PI3K (AF6241), p-PI3K (AF3241) (both 1:1000, Affinity), AKT (ET1609-47), p-AKT (ET1607-73) (both 1:500, HuaBio), Bax (ab32503), Caspase-3 (ab184787) and Bcl-2 (ab196495) (all 1:2000, Abcam). Additionally, 740 Y-P (HY-P0175), a potent, cell-permeable PI3K activator, was acquired from MedChemExpress (MCE, USA).
The OSCC cell lines HSC-3 and CAL-27, identified by Short Tandem Repeat(STR) analysis, along with the normal oral mucosal epithelial cell line HOK, were cultured in Dulbecco's Modified Eagle Medium(DMEM) medium encompassing 1% penicillin and streptomycin and 10% Fetal Bovine Serum(FBS). The culturing procedure was carried out in a humid environment in an incubator with 5% CO 2 at 37 °C. The selection of CAL-27 and HSC-3 cell lines was based on our specific research content. Both CAL-27 and HSC-3 are tongue squamous cell lines, and tongue cancer has the highest metastasis rate among oral and maxillofacial cancers. Most of our research content is about migration and invasion, and MMP9, a molecule we screened, is also an important molecule in the EMT process, so we chose the above two cell lines in this study.
The cell density was adjusted to 5 × 10 3 cells per well, and the cells were seeded into 96-well plates. After an attachment period of 8 h, HSC-3, and CAL-27 cells underwent treatment with varying cardamonin concentrations (0, DMSO, 10, 20, 40, 80, and 160 µmol/L), with DMSO concentration representing the concentration added during cardamonin dilution. A control group with only DMSO was included to account for its potential effect on the cells. Each group was set up with three replicate wells. Following incubation for 24 h, 10 µL of CCK-8 reagent was introduced to all wells, and the optical density (OD) value was measured at 450 nm utilizing an enzyme marker after a 2 h incubation period. The 50% inhibitory concentration(IC50)values for cardamonin concentrations of 0, 10, 20, and 40 µmol/L were selected for further investigation based on their respective values at 24 h.
HSC-3 and CAL-27 cells underwent treatment with cardamonin (0, 10, 20, and 40 µmol/L), respectively.
The cell density was adjusted to 1 × 10 3 cells/well and seeded into 6-well plates. After cell attachment for 8 h, the cells underwent treatment as described previously, with each group having three replicate wells. Following 24 h of treatment with cardamonin, the complete medium was changed, and the cells underwent incubation for an additional 12 days. Subsequently, the cells underwent fixation utilizing 4% paraformaldehyde and staining using 0.1% crystal violet. The quantification of colony numbers was conducted utilizing ImageJ software.
CAL-27 and HSC-3 cells were seeded into 6-well plates at a density of 3 × 10 5 cells per well, with 2 ml of 10% FBS medium. The plates were then kept in an incubator with 5% CO 2 and a constant temperature of 37 °C for cell culture. Once the cell density reached 100%, use the yellow tip to draw a straight line horizontally across the diameter of the six-well plate.. Caution was taken to ensure uniformity in drawing the line to maintain consistent well widths. Immediately after drawing the line, photos were captured using an inverted microscope, and the photo position of each well was recorded. Subsequently, 2 ml of DMEM culture medium without FBS was introduced into each well, and the cells were treated with cardamonin according to the same treatments and groupings as before. After 24 h of cardamonin treatment, the cell scratch healing rate was determined at the same position where the line was drawn initially. The following formula was utilized to calculate the cell scratch healing rate: Cell scratch healing rate = [(0 h scratch area- 24 h scratch area)/0 h scratch area] × 100%.
Before the experiment, the matrix gel was diluted at a ratio of 1:8 with DMEM culture medium without FBS and set aside. The diluted matrix gel was introduced vertically into the inner lateral membrane of the chambers. HSC-3 and CAL-27 were digested and resuspended with a double-free medium containing different concentrations of cardamonin, treated and grouped as before. The cells were counted and inoculated on the inner membrane of the chamber at a density of 5 × 10 4 cells/well, with 200ul 10% FBS medium. Different concentrations of cardamonin were added to the corresponding well plates below the chamber, and the cells were treated and grouped as before. After 24 h, the medium in the 24-well plate and the chamber was removed, and the cells were fixed by adding 4% paraformaldehyde solution. Crystal violet staining solution was then introduced to stain the cells. The plate underwent washing with PBS three times, and the inside of the chamber was gently wiped with a cotton swab to eliminate excess dye. Subsequently, the plate was air-dried, images were captured, and the number of cells in each field of view was quantified.
The cell lysates were prepared on ice utilizing RIPA buffer, PMSF and Protein Phosphatase Inhibitor (All-in-one, 100x) (Solarbio, Beijing, China), after which centrifugation was executed to acquire the supernatant. Subsequently, its protein concentration was assessed utilizing a BCA kit (Solarbio). Next, the proteins underwent denaturation by heating at 100 °C. Equivalent quantities of protein were isolated by 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) gel, with a subsequent transfer onto polyvinylidene difluoride membranes. The membranes then underwent blocking with 5% milk in TBS-T at room temperature for 2 h. Subsequent to blocking, the membranes underwent overnight exposure to the primary antibody. Then, the membranes were further exposed to secondary antibodies at room temperature. Visualization of the protein bands was conducted utilizing an ECL kit, and densitometric analysis was executed utilizing ImageJ software.
CAL-27 and HSC-3 cells were inoculated into 6 cm diameter dishes with 3 mL of 10% FBS medium/well. The dishes were then placed in an incubator with 5% CO 2 at a constant temperature of 37 °C for cell culture. Once the cell density reached 50–70%, the cells were treated with cardamonin as previously described. Following 24 h of cardamonin treatment, the cells underwent digestion with EDTA-free trypsin, followed by centrifugation to discard the supernatant. After this, cells underwent washing thrice with PBS solution and then were resuspended in 500 µL PBS solution. The cells were then stained following the procedure provided in the Annexin V-FITC/PI double-labeling staining kit. Subsequently, the stained cells were examined utilizing a flow cytometer, and the sums of early and late apoptosis were calculated for each group.
Data were examined utilizing GraphPad Prism v9.0 statistical software. Each experiment was replicated three times. The data are presented as the mean ± standard deviation (SD). Variations between two or more groups were assessed utilizing the Student’s t-test or one-way analysis of variance. P < 0.05 was deemed as a statistically significant value.
Cardamonin, a chemical substance extracted from the ginger plant Myristica fragrans , is depicted by its chemical structural formula in Fig. 2 a. To elucidate potential targets of cardamonin in OSCC, the Canonical SMILES number of cardamonin was retrieved from the PubChem database. Subsequently, 100 targets associated with the activity of cardamonin were identified through the Swiss Target Prediction database.
PPI networks and key targets. ( a ) Chemical structure of cardamonin. ( b ) Venn diagram of intersecting targets of cardamonin and OSCC, with 72 intersecting targets. ( c ) PPI network of cardamonin for OSCC. ( d ) Key target genes of cardamonin against OSCC. The redder and larger the node, the more significant it is in the network.
To further narrow down potential targets relevant to OSCC, 6729 targets related to OSCC were screened using the GeneCards database. From this screening, 3089 genes associated with OSCC were identified based on association scores exceeding the median value of 14.45.
Additionally, 429 target genes associated with OSCC were obtained from OMIM. By merging and eliminating duplicate data, 3351 OSCC-related target genes were compiled.
By intersecting these datasets, 72 potential targets of cardamonin in OSCC were identified using the Wayne online tool (Fig. 2 b).
The intersecting targets of cardamonin and OSCC were uploaded to the String platform, with the species set as "Homo sapiens", and unconnected nodes in the network were hidden. Default parameters were applied to acquire protein interaction data and construct the PPI network (Fig. 2 c), which comprised 72 nodes interacting through 417 edges.
Subsequently, the protein interaction data were imported into Cytoscape 3.7.1 software. Topological analysis was conducted using the Centiscape2.2 plug-in, resulting in the identification of 14 core targets based on Degree ≥ 11.58333, Betweenness ≥ 73.94444, and Closeness ≥ 0.007040748 criteria. The screening yielded 14 nodes and 67 edges, which were then visualized and analyzed (Fig. 2 d).
The analysis revealed that ESR1, EGFR, CXCR4, MMP9, HSP90AB1, PTGS2, PPARG, APP, FLT1, MCL1, PRKCA, PTK2, TERT, and HSPA8 are the core target genes of cardamonin in its action against OSCC.
The 72 potential targets of cardamonin acting on OSCC underwent GO enrichment analysis, which encompassed three parts: biological process (BP), cellular component (CC), and molecular function (MF) 29 . The GO enrichment analysis generated 288 GO items, including 172 BPs, 40 CCs, and 76 MFs.
After excluding the enrichment results with P > 0.05 and sorting them according to the count value, the top 10 items of each module were visualized using the microbiology letter platform (Fig. 4 a). The BP category mainly involved negative regulation of transcription from RNA polymerase II promoter, negative regulation of apoptotic signaling pathway, positive regulation of cell proliferation, etc. The CC category mainly involved the cytosol, plasma membrane, etc. The MF category primarily involved ATP binding, enzyme binding, protein binding, etc., indicating the importance of proteins in disease.
Pathways with P < 0.05 were screened according to the enrichment results, resulting in 59 KEGG pathways that were enriched and sorted as per the COUNT value. The top 20 pathways were chosen to create visualized bubble diagrams using the microbiology letter platform (Fig. 4 b). The results showed that the relevant signaling pathways of cardamonin acting on OSCC were the PI3K-Akt and MAPK pathways, among others. Notably, the PI3K/AKT pathway exhibited a higher degree of enrichment.
The PI3K-Akt pathway is a key signaling pathway regulating cell proliferation and motility, thereby contributing to cell survival. Its activation can contribute to the aberrant proliferation of OSCC cells.
Molecular docking has been widely used to study possible binding patterns between molecules. In this study, molecular docking technology was used to explore the optimal binding mode of cardamonin to six proteins (Fig. 3 ). The docking results listed the binding energy, interaction force and bond length information for molecular docking (Table 1 ). The binding energy of cardamonin with MMP9, EGFR, ESR1, HSP90AB1, PPARG and PTGS2 reached − 8.5 kcal/mol, − 7.5 kcal/mol, − 6.2 kcal/mol, − 8.3 kcal/mol, respectively. − 7.7 kcal/mol and − 8.1 kcal/mol are bonded by hydrogen bonding, hydrophobic interactions and π-stacking. Among them, MMP9 has the lowest binding energy and the best binding effect.
Molecular docking analysis. MMP9, EGFR, ESR1, HSP90AB1, PPARG, and PTGS2 were selected as receptors, and cardamonin was selected as ligand. Hydrogen bonds, hydrophobic interactions, and π-stacking are shown in yellow, blue, and green, respectively.
To explore the expression level of the core target gene MMP9 in relation to the development of head and neck squamous carcinoma (HNSC), gene expression data were retrieved from The Cancer Genome Atlas (TCGA) database. The expression data of the target gene MMP9 were assessed in individuals with HNSC and compared with the normal population.
The outcomes highlighted that the expression of MMP9 was increased in HNSC patients relative to the normal population, and this difference was observed to be statistically significant (Fig. 4 c).
Common target gene enrichment analysis and validation of important target genes. ( a ) Functional enrichment analysis encompassing BP, CC, and MF categories. ( b ) KEGG pathway enrichment analysis. Dot size and color represent the no. of genes and corrected P -value, respectively. ( c ) Data from the UALCAN database show that MMP9 exhibits enhanced expression in OSCC.
To examine the impact of cardamonin on the activity of OSCC cell lines CAL-27 and HSC-3, along with human normal keratinocytes (HOK), cells underwent treatment with increasing concentrations of cardamonin (0, 10, 20, 40, 80, 160 μmol/L) for 24 h. Subsequently, the IC50 values of the drug required to inhibit 50% of cell growth (IC50) were determined utilizing the CCK-8 assay. The findings highlighted that the IC50 values for CAL-27 and HSC3 cells were 41.28 μmol/L and 41.24 μmol/L, respectively. This indicates that the activity of OSCC cells decreased in a concentration-dependent manner with increasing concentrations of cardamonin (Fig. 5 a–c). However, at concentrations below 80 μmol/L of cardamonin in the treatment of human HOK cells, cardamonin did not exhibit a considerable inhibitory impact on the activity of HOK cells. This suggests that low concentrations of cardamonin do not have significant toxicity to normal oral epithelial cells. Conversely, cardamonin demonstrated a considerable inhibitory impact on the proliferation of OSCC cells. This finding supports the safety of using cardamonin for the treatment of OSCC. To further elucidate the impact of cardamonin on the proliferative capacity of OSCC cells, a clone formation assay was utilized to examine the clone formation ability of CAL-27 and HSC-3 cells subjected to treatment with various concentrations of cardamonin. The findings highlighted that cardamonin displayed a concentration-dependent inhibitory impact on the proliferative capacity of OSCC cells. Notably, nearly complete inhibition of cancer cell proliferation was observed when treated with 40 μmol/L of cardamonin (Fig. 5 d). These results underscore the concentration-dependent inhibition of OSCC cell proliferation by cardamonin.
Effect of cardamonin on OSCC cell activity. Cells underwent treatment with various concentrations (0, 10, 20, 40, 80, 160 µmol/L) for 24 h, and the cytotoxic impact of cardamonin on CAL27 cells ( a ) and HSC3 cells ( b ) was detected utilizing the CCK-8 assay. ( c ) The impact of cardamonin on the activity of three types of cells, namely, CAL-27, HSC-3, and HOK, was detected using the CCK-8 assay. ( d ) Cells underwent treatment with various concentrations (0, 10, 20, and 40 µmol/L) for 12 d. The clone formation ability of cardamonin on CAL27 and HSC3 cells was examined by cell clone formation assay. The data were expressed as mean ± SD (n = 3) and compared with the control group, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
To investigate the impact of cardamonin on the migratory and invasive capabilities of OSCC cells, scratch assays were carried out to determine the migratory capacity of OSCC cells following treatment with various concentrations of cardamonin (0, 10, 20, and 40 μmol/L). The results demonstrated a significant inhibitory effect on the migration of CAL-27 and HSC-3 cells treated with cardamonin, with the inhibitory effect being concentration-dependent (Fig. 6 a). Additionally, transwell migration and invasion assays were executed, revealing a reduction in both migratory and invasive abilities of CAL-27 and HSC-3 cells following treatment with cardamonin (Fig. 6 b). MMP9 emerges as the primary binding target for cardamonin in OSCC cells, functioning as a pivotal regulator in the epithelial-mesenchymal transition (EMT) process. EMT, known for promoting cell migration and invasion 30 , implies that cardamonin might impede these processes by binding to MMP9 and inhibiting EMT. To substantiate this hypothesis, this study assessed the expression of molecules related to EMT. The findings revealed that cardamonin upregulated the epithelial marker protein E-cadherin while reducing the levels of mesenchymal proteins, including N-cadherin, vimentin, and snail. Additionally, the expression of MMP9 protein, a key target of cardamonin, was also downregulated (Fig. 6 c,d). These findings strongly indicate that cardamonin exerts its inhibitory impact on OSCC cell migration and invasion by targeting MMP9 to suppress the occurrence of EMT.
Migration and invasion of CAL-27 and HSC-3 cell lines and expression of related proteins. ( a ) Cell migration of CAL-27 and HSC-3 cell lines at different concentrations of cardamonin experimental group compared with 0 concentration. ( b ) Cell invasive migration of CAL-27 and HSC-3 cell lines at different concentrations of cardamonin experimental group compared with 0 concentration. ( c , d ) The protein banding display and relative gray value analysis and relative protein expression of E-cadherin, N-cadherin, MMP9, Vimentin, and Snail in each group of CAL-27 and HSC-3 cell lines were assessed. The findings highlighted that the expression of epithelial-associated protein E -cadherin was enhanced, and the expression of mesenchymal-associated proteins N -cadherin, Vimentin, and Snail was decreased. The OSCC target protein MMP9 was significantly reduced by cardamonin treatment. The variation in expression was statistically significant. Data were expressed as mean, standard deviation (n ≥ 3), ns P > 0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Further investigation was conducted to ascertain whether cardamonin inhibited cancer cell proliferation by facilitating apoptosis in OSCC cells. The outcomes suggested a considerable elevation in the proportion of Annexin V+ cells in CAL-27 and HSC-3 cells upon treatment with cardamonin, as determined by Annexin-V/PI flow cytometry. Notably, the proportion of Annexin V+ cells increased with higher concentrations of cardamonin (Fig. 7 a), indicating that cardamonin promotes apoptosis of OSCC cells in a concentration-dependent manner.
Cardamonin promoted apoptosis in CAL-27, HSC-3 cells via PI3K/AKT signaling pathway. ( a ) Apoptosis of CAL-27 and HSC-3 cell lines in different concentrations of cardamonin experimental groups compared with 0 concentration. ( b ) Protein band display and relative gray value analysis of PI3K, p-PI3K, AKT, p-AKT, and relative expression of proteins in CAL-27 and HSC-3 cell lines. ( c ) Protein band display and relative gray value analysis of p-PI3K, PI3K, p-AKT, and AKT in CAL-27 and HSC-3 cell lines in all groups were performed, wherein protein bands were displayed and analyzed for relative gray value and relative expression of proteins. The results showed enhanced expression of BAX and Cleaved-caspase3 and reduced expression of Bcl-2 and pro-caspases3. ( d ) Protein expression levels of PI3K, p-PI3K, AKT, p-AKT, and relative expression of proteins in the reverse experiments of CAL-27 and HSC-3 cell lines. Expression differences were statistically significant. Data are expressed as mean, standard deviation (n ≥ 3), ns P > 0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Apoptosis represents an active and signaling-dependent process crucial for regulating cell death. Caspase-3 serves as the effector molecule responsible for executing apoptosis. Its activation marks a critical step that irreversibly commits the cell to undergo apoptosis 31 . Within the Bcl-2 family, two key molecules are notably significant: Bcl-2 and Bax. Western blot analysis highlighted that cardamonin treatment reduced the expression of apoptosis-related proteins in CAL-27 and HSC-3 cells. Furthermore, cardamonin treatment led to a reduction in pro-caspase-3 expression and an increase in cleaved-caspase-3 expression (Fig. 7 c). Notably, these effects became more pronounced with increasing concentrations of cardamonin. In the previously discussed network pharmacology analysis, cardamonin was proposed to potentially induce apoptosis in OSCC cells by partially modulating the PI3K-AKT pathway. Abnormal activation of the PI3K/Akt pathway is known to promote the progression of OSCC by suppressing apoptosis, increasing drug resistance, facilitating angiogenesis, promoting metastasis, and inducing EMT 32 . Subsequently, further experiments were conducted to validate the hypothesis. Western blot analysis revealed that treatment with cardamonin contributed to a reduction in the protein expression levels of p-PI3K and p-AKT in CAL-27 and HSC-3 cells ( P < 0.05) (Fig. 7 b). These findings highlighted that cardamonin induced apoptosis in OSCC cells by partially suppressing the PI3K/AKT pathway.
Finally, a reverse experiment was performed by adding a PI3K activator. Western blotting analysis results indicated that the expression of p-AKT, p-PI3K, and apoptosis-associated proteins in the group treated with both cardamonin and the PI3K activator notably rebounded compared to the group treated with cardamonin alone (Fig. 7 d).
OSCC stands as the most common cancer affecting the oral and maxillofacial region 33 . Despite significant strides made in the diagnosis and treatment of OSCC, its mortality rate remains high, with the 5-year survival rate remaining below 50% 34 . Typically, OSCC is treated through a comprehensive treatment strategy tailored to the type, location, and stage of cancer, often prioritizing surgical intervention followed by adjuvant chemoradiotherapy 35 . Post-surgery, OSCC patients commonly experience compromised functions such as chewing, swallowing, and speaking, consequently diminishing their quality of life and significantly impacting their physical and mental well-being 36 .
Natural phytochemicals are increasingly recognized as valuable adjuncts in postoperative care and as prophylactic measures against recurrence owing to their favorable tolerability, safety profile, low toxicity, and antioxidant properties 37 . Resistance to chemotherapeutic agents significantly impacts the effectiveness of OSCC treatment, and natural plant-derived compounds offer promise in improving therapeutic outcomes while mitigating side effects, besides their inherent ability to impede tumor progression. The impact of herbal components on OSCC has been extensively investigated. Studies have revealed that herbal compounds like cryptotanshinone 38 , glaucoma oleocalyxin A 39 , and duchesnea 40 possess the ability to impede the growth of OSCC via various mechanisms and signaling pathways. Cardamonin has demonstrated its ability to facilitate tumor cell apoptosis in several cancer types, including breast 12 , liver 41 , and colorectal cancers 14 . These outcomes suggest the potential of cardamonin as a therapeutic agent in oncology. Cardamonin, as a natural active ingredient, can target various links of tumor occurrence and development through multiple ways, showing great potential in the prevention and treatment of malignant tumors. However, it also has a series of defects such as poor water solubility, low bioavailability and strong irritation 42 . In recent years, the application of nanotechnology and hydrogels has effectively improved the bioavailability, and further studies on the efficacy and toxicity reduction of cardamonin should be strengthened to improve the bioavailability. Drug combination has always been the core drug principle in the field of anti-tumor. Cisplatin, as a first-line high-efficiency broad-spectrum anti-tumor drug, has relatively serious adverse reactions. Cardamonin can significantly reduce cisplatin induced kidney injury and synergically promote the anti-tumor effect of cisplatin 43 . However, there is limited research on the therapeutic effects of cardamonin, specifically on OSCC.
This research examined the key targets and potential mechanisms of cardamonin in treating OSCC using an integrated approach that combines molecular docking, network pharmacology, and in vitro experiments. Our findings suggest that cardamonin promotes apoptosis in OSCC cells by partially inhibiting the PI3K/AKT pathway. Through PPI network analysis, MMP9, EGFR, PTGS2, PRKCA, PPARG, and FLT1 were identified as the key targets involved in the treatment process of cardamonin on OSCC.
Matrix metalloproteinase 9 (MMP9) is an enzyme produced by cells and belongs to the matrix metalloproteinase family. It serves pivotal functions in both physiological and pathological processes, encompassing cell migration, tissue repair, and cell proliferation 44 . However, overexpression or enhanced activity of MMP9 has been linked to several inflammatory conditions and diseases, encompassing chronic obstructive pulmonary disease 45 , cardiovascular disease 46 , and tumor metastasis 47 . Given their relevance to the occurrence and metastasis of OSCC, these pivotal targets exhibited stronger binding affinity for cardamonin during molecular docking studies, suggesting its potential as an anti-OSCC agent.
To further corroborate the efficacy of cardamonin in addressing OSCC, OSCC cells were exposed to various concentrations of the compound. Subsequently, the IC50 values for different cell lines were determined after 24 h. It was observed that cardamonin exhibited concentration-dependent inhibition of OSCC cell proliferation, as evidenced by both the CCK-8 assay and clone formation assay.
Apoptosis denotes an orderly regulated mechanism of cell demise, transpiring under either physiological or pathological circumstances 48 . Dysregulated apoptosis stands as a primary contributor to human cancer development. The majority of anticancer therapies are designed to induce apoptosis in tumor cells, aiming to eradicate malignant cells 49 . Our flow cytometry analysis highlighted that cardamonin can enhance apoptosis in a concentration-dependent manner. The Bcl-2 family members and caspases play pivotal roles in regulating cell apoptosis 50 . Within the Bcl protein family, Bcl-2 exerts an anti-apoptotic influence by impeding the release of cytochrome c, whereas Bax exerts a pro-apoptotic influence by facilitating cytochrome c release. The balance between Bcl-2 and Bax governs the apoptotic status of cells 51 . Caspase-3 serves as a downstream enzyme performing the apoptosis process and stands as the foremost regulator of cell demise. Upon cleavage by proteases, the Caspase-3 zymogen undergoes activation, yielding cleaved Caspase-3, thereby amplifying the protease cascade and ultimately instigating apoptosis within the nucleus 52 . This research found that cardamonin inhibited the expression levels of Bcl-2 and pro-Caspase-3, while significantly promoting the expression levels of Bax and cleaved Caspase-3 in OSCC cells. These findings further corroborate the notion that cardamonin has the potential to promote apoptosis in OSCC cells.
KEGG analysis revealed that cardamonin primarily regulates the RAS, PI3K/Akt, and MAPK signaling pathways in OSCC. Subsequent in vitro experiments demonstrated the inhibitory impact of cardamonin on PI3K activation. The PI3K-AKT pathway represents one of the most frequently dysregulated molecular pathways in human cancers, driving carcinogenesis by impeding normal apoptosis via the activation of various downstream effectors 53 . Previous studies underscore the involvement of the PI3K-Akt pathway in the development of multiple tumors. To further elucidate the inhibitory action of cardamonin on the PI3K/AKT pathway in OSCC, a significant reversal of the inhibitory impact of cardamonin was noted upon the addition of a PI3K agonist. This was accompanied by an elevation in the expression levels of p-PI3K and p-AKT, alongside a considerable elevation in the expression of apoptosis-related proteins encompassing BCL-2, pro-caspase 3, BAX, and cleaved-caspase 3 induced by the PI3K agonist. These outcomes highlight that cardamonin could facilitate OSCC cell apoptosis through the PI3K-Akt pathway. Furthermore, our findings revealed that cardamonin could impede tumor cell migration and invasion by inhibiting EMT. An abstract representation of the article is illustrated in Fig. 8 .
Mechanism of apoptosis promotion in oral squamous cell carcinoma cells by cardamonin.
This study highlights that cardamonin exhibits the potential to promote apoptosis in OSCC cells by suppressing the PI3K/AKT pathway activation. Furthermore, the results of this research lay a solid theoretical basis for the utilization of cardamonin as a natural drug in treating OSCC ( Supplementary Information ).
All raw data are publicly available from corresponding databases. Processed data are available upon reasonable request from the corresponding author.
Kina, S. et al. Higher overall survival rates of oral squamous cell carcinoma treated with metronomic neoadjuvant chemotherapy. Am. J. Cancer Res. 14 (3), 1033–1051. https://doi.org/10.62347/EYNT8387 (2024).
Article CAS PubMed PubMed Central Google Scholar
Madera, M., Tirado Amador, L. & Leal, A. C. Therapeutic options in unresectable oral squamous cell carcinoma: A systematic review. Cancer Manag. Res. 13 , 6705–6719. https://doi.org/10.2147/CMAR.S283204 (2021).
Article PubMed PubMed Central Google Scholar
He, Y. et al. Lipid droplets-related Perilipin-3: Potential immune checkpoint and oncogene in oral squamous cell carcinoma. Cancer Immunol. Immunother. 73 (5), 78. https://doi.org/10.1007/s00262-024-03659-9 (2024).
Mann, J. Natural products in cancer chemotherapy: Past, present and future. Nat. Rev. Cancer 2 (2), 143–148. https://doi.org/10.1038/nrc723 (2002).
Article MathSciNet CAS PubMed Google Scholar
Zhu, H. et al. Dandelion root extract suppressed gastric cancer cells proliferation and migration through targeting lncRNA-CCAT1. Biome. Pharmacother. 93 , 1010–1017. https://doi.org/10.1016/j.biopha.2017.07.007 (2017).
Article CAS Google Scholar
Kubatka, P. et al. Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling. Cancer Metastasis Rev. https://doi.org/10.1007/s10555-023-10134-x (2023).
Chen, H. et al. Cardamonin suppresses pro-tumor function of macrophages by decreasing M2 polarization on ovarian cancer cells via mTOR inhibition. Mol. Ther. Oncol. 26 , 175–188. https://doi.org/10.1016/j.omto.2022.06.009 (2022).
Liu, Z., He, Z., Ai, X., Guo, T. & Feng, N. Cardamonin-loaded liposomal formulation for improving percutaneous penetration and follicular delivery for androgenetic alopecia. Drug Deliv. Transl. Res. https://doi.org/10.1007/s13346-024-01519-8 (2024).
Article PubMed Google Scholar
Kim, Y. J., Kang, K. S., Choi, K. C. & Ko, H. Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells. Bioorg. Med. Chem. Lett. 25 (12), 2559–2564. https://doi.org/10.1016/j.bmcl.2015.04.054 (2015).
Article CAS PubMed Google Scholar
Chen, H., Shi, D., Niu, P., Zhu, Y. & Zhou, J. Anti-inflammatory effects of cardamonin in ovarian cancer cells are mediated via mTOR suppression. Planta Med. 84 (16), 1183–1190. https://doi.org/10.1055/a-0626-7426 (2018).
Park, M. K. et al. Novel anti-nociceptive effects of cardamonin via blocking expression of cyclooxygenase-2 and transglutaminase-2. Pharmacol. Biochem. Behav. 118 , 10–15. https://doi.org/10.1016/j.pbb.2013.12.019 (2014).
Jia, D. et al. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo. Oncotarget 7 (1), 771–785. https://doi.org/10.18632/oncotarget.5819 (2016).
Hossan, M. S. et al. Novel semi-synthetic Cu (II)-cardamonin complex exerts potent anticancer activity against triple-negative breast and pancreatic cancer cells via inhibition of the Akt signaling pathway. Molecules 26 (8), 2166. https://doi.org/10.3390/molecules26082166 (2021).
Lu, T., Zheng, C. & Fan, Z. Cardamonin suppressed the migration, invasion, epithelial mesenchymal transition (EMT) and lung metastasis of colorectal cancer cells by down-regulating ADRB2 expression. Pharm. Biol. 60 (1), 1011–1021. https://doi.org/10.1080/13880209.2022.2069823 (2022).
Wang, Z. et al. Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway. J. Cancer 12 (12), 3597–3610. https://doi.org/10.7150/jca.55519 (2021).
Pei, H. et al. Network pharmacology and molecular docking analysis on the mechanism of Cordyceps militaris polysaccharide regulating immunity through TLR4/TNF-α pathwayss. J. Biochem. Mol. Toxicol. 37 (6), e23345. https://doi.org/10.1002/jbt.23345 (2023).
Liu, S., Zhang, Q., Liu, W. & Huang, X. Research on the mechanisms of Shu Yu wan in the treatment of cervical cancer based on network pharmacology analyses and molecular docking technology. Nat. Prod. Rese. 37 (4), 646–650. https://doi.org/10.1080/14786419.2022.2071884 (2023).
Wu, H. B., Xiao, Y. G., Chen, J. S. & Qiu, Z. K. The potential mechanism of Bupleurum against anxiety was predicted by network pharmacology study and molecular docking. Metab. Brain Dis. 37 (5), 1609–1639. https://doi.org/10.1007/s11011-022-00970-1 (2022).
Navaei, Z. N. et al. PI3K/Akt signaling pathway as a critical regulator of cisplatin response in tumor cells. Oncol. Res. 29 (4), 235–250 (2022).
Glaviano, A. et al. PI3K/Akt/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer. 22 (1), 138 (2023).
Tewari, D. et al. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy. Semin. Cancer Biol. 80 , 1–17 (2022).
Brkic, M. et al. Friends or foes: Matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediators Inflamm. 2015 , 620581. https://doi.org/10.1155/2015/620581.1 (2015).
Bonnans, C., Chou, J. & Werb, Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15 (12), 786–801 (2014).
Opdenakker, G. et al. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69 (6), 851–859 (2001).
Kim, S., Chen, J. & Cheng, T. PubChem 2023 update. Nucleic Acids Res. 51 (D1), D1373–D1380. https://doi.org/10.1093/nar/gkac956 (2023).
Gfeller, D., Grosdidier, A. & Wirth, M. L. SwissTargetPrediction: A web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42 (Web Server issue), W32-38. https://doi.org/10.1093/nar/gku293 (2014).
Rebhan, M., Chalifa-Caspi, V. & Prilusky, J. GeneCards: Integrating information about genes, proteins and diseases. Trends Genet. 13 (4), 163. https://doi.org/10.1016/s0168-9525(97)01103-7 (1997).
Cline, M. S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2 (10), 2366–2382. https://doi.org/10.1038/nprot.2007.324 (2007).
Hopkins, A. L. Network pharmacology. Nat. Biotechnol. 25 (10), 1110–1111. https://doi.org/10.1038/nbt1007-1110 (2007).
Pastushenko, I. & Blanpain, C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29 (3), 212–226. https://doi.org/10.1016/j.tcb.2018.12.001 (2019).
Alzahrani, A. S. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. Semin. Cancer Biol. 59 , 125–132. https://doi.org/10.1016/j.semcancer.2019.07.009 (2019).
Wang, J. et al. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway. Cell Death Dis. 11 (8), 682. https://doi.org/10.1038/s41419-020-02851-w (2020).
Ai, Y. et al. METTL3 intensifies the progress of oral squamous cell carcinoma via modulating the m6A amount of PRMT5 and PD-L1. J. Immunol. Res. 2021 , 6149558. https://doi.org/10.1155/2021/6149558 (2021).
Wang, J., Du, X. X., Jiang, H. & Xie, J. X. Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem. Pharmacol. 78 (2), 178–183. https://doi.org/10.1016/j.bcp.2009.03.031 (2009).
Sun, S. et al. MiR-302b suppresses tumor metastasis by targeting frizzled 6 in OSCC. J. Dent. Res. 100 (7), 739–745. https://doi.org/10.1177/0022034520986551 (2021).
Wang, Z. et al. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma. Br. J. Cancer https://doi.org/10.1038/s41416-024-02670-2 (2024).
Ji, Y. et al. IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation. Cancer Lett. 589 , 216833. https://doi.org/10.1016/j.canlet.2024.216833 (2024).
Jiang, X. T., Qiu, Y. & Li, C. H. Cryptotanshinone inhibits oral squamous cell carcinoma through the autophagic pathway. Neoplasma 70 (1), 114–122. https://doi.org/10.4149/neo_2023_220924N957 (2023).
Wang, X., He, M. J., Chen, X. J., Bai, Y. T. & Zhou, G. Glaucocalyxin A impairs tumor growth via amplification of the ATF4/CHOP/CHAC1 cascade in human oral squamous cell carcinoma. J. Ethnopharmacol. 290 , 115100. https://doi.org/10.1016/j.jep.2022.115100 (2022).
Yang, W. E. et al. Duchesnea indica extract attenuates oral cancer cells metastatic potential through the inhibition of the matrix metalloproteinase-2 activity by down-regulating the MEK/ERK pathway. Phytomed. Int. J. Phytother. Phytopharmacol. 63 , 152960. https://doi.org/10.1016/j.phymed.2019.152960 (2019).
Xu, Q. et al. Cardamonin reduces acetaminophen-induced acute liver injury in mice via activating autophagy and NFE2L2 signaling. Front. Pharmacol. 11 , 601716. https://doi.org/10.3389/fphar.2020.601716 (2020).
Liu, Z., He, Z., Ai, X., Guo, T. & Feng, N. Cardamonin-loaded liposomal formulation for improving percutaneous penetration and follicular delivery for androgenetic alopecia. Drug Deliv. Transl. Res. 14 (9), 2444–2460. https://doi.org/10.1007/s13346-024-01519-8 (2024).
El-Naga, R. N. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: Impact on NOX-1, inflammation and apoptosis. Toxicol. Appl. Pharmacol. 274 (1), 87–95. https://doi.org/10.1016/j.taap.2013.10.031 (2014).
Hosseini, A., Kumar, S., Hedin, K. & Raeeszadeh-Sarmazdeh, M. Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display. Protein Sci. 32 (12), e4795. https://doi.org/10.1002/pro.4795 (2023).
Jiang, J. et al. CD146 deficiency aggravates chronic obstructive pulmonary disease via the increased production of S100A9 and MMP-9 in macrophages. Int. Immunopharmacol. 127 , 111410. https://doi.org/10.1016/j.intimp.2023.111410 (2024).
Bhave, S. et al. Loss of bone morphogenetic protein-9 reduces survival and increases MMP activity after myocardial infarction. JACC Basic Transl. Sci. 8 (10), 1318–1330. https://doi.org/10.1016/j.jacbts.2023.05.017 (2023).
Wu, S., Liu, L., Xu, H., Zhu, Q. & Tan, M. The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer. Cancer Biol. Ther. 24 (1), 2249174. https://doi.org/10.1080/15384047.2023.2249174 (2023).
Wong, R. S. Y. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30 (1), 87. https://doi.org/10.1186/1756-9966-30-87 (2011).
Mohammad, R. M. et al. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol. 35 (Suppl 0), S78–S103. https://doi.org/10.1016/j.semcancer.2015.03.001 (2015).
Herr, A. B. Evolution of an allosteric “off switch” in apoptotic caspases. J. Biol. Chem. 293 (15), 5462–5463. https://doi.org/10.1074/jbc.H118.002379 (2018).
Ghobrial, I. M., Witzig, T. E. & Adjei, A. A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 55 (3), 178–194. https://doi.org/10.3322/canjclin.55.3.178 (2005).
Crawford, E. D. & Wells, J. A. Caspase substrates and cellular remodeling. Annu. Rev. Biochem. 80 , 1055–1087. https://doi.org/10.1146/annurev-biochem-061809-121639 (2011).
Wang, Y. et al. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. J. Ethnopharmacol. 279 , 114399. https://doi.org/10.1016/j.jep.2021.114399 (2021).
Download references
Thanks to the Innovation Centre for Science and Technology of North Sichuan Medical College and the Institute of Hepatobiliary, Pancreatic and Intestinal Diseases of North Sichuan Medical College for their research platform and support. We thank Bullet Edits Limited for the linguistic editing and proofreading of the manuscript.
Funded Projects: Key Training Project of North Sichuan Medical College (CBY23-ZDA10), Cooperation Project of Nanchong University (22SXQT0356-Yu). The funder was not involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
These authors contributed equally: Yuehan Wu and Yapei Wang.
Department of Stomatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China
Yuehan Wu, Yapei Wang, Han Liu, Qiannan Hu, Xiaoxu Nan, Huan He & Ying Liu
Department of Stomatology, North Sichuan Medical College, Nanchong, China
Yuehan Wu, Yapei Wang, Han Liu, Yuqi Xie, Xiaoxu Nan & Ying Liu
You can also search for this author in PubMed Google Scholar
Conceptualization: Yuehan Wu, Yapei Wang, Xiaoxu Nan. Data curation: Yuehan Wu, Huan He. Formal analysis: Yuehan Wu. Methodology: Qiannan Hu, Yuqi Xie. Project administration: Ying Liu. Supervision: Ying Liu. Validation: Yuqi Xie. Visualization: Yuehan Wu. Writing—original draft: Yuehan Wu. Writing—review and editing: Yuehan Wu, Han Liu.
Correspondence to Ying Liu .
Competing interests.
The authors declare no competing interests.
Publisher's note.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information 1., supplementary information 2., supplementary information 3., supplementary information 4., rights and permissions.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ .
Reprints and permissions
Cite this article.
Wu, Y., Wang, Y., Liu, H. et al. Mechanism of apoptosis in oral squamous cell carcinoma promoted by cardamonin through PI3K/AKT signaling pathway. Sci Rep 14 , 20802 (2024). https://doi.org/10.1038/s41598-024-71817-1
Download citation
Received : 22 May 2024
Accepted : 30 August 2024
Published : 05 September 2024
DOI : https://doi.org/10.1038/s41598-024-71817-1
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
By submitting a comment you agree to abide by our Terms and Community Guidelines . If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.
Price: $3699.
Historical Period | 2019-2022 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Dental Laboratories Market Size 2024 | USD 58,611.00 million |
Dental Laboratories Market, CAGR | 5.30% |
Dental Laboratories Market Size 2032 | USD 88,594.36 million |
The Dental Laboratories Market is projected to grow from USD 58,611.00 million in 2024 to USD 88,594.36 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.30%.
The Dental Laboratories Market is driven by the growing demand for advanced dental prosthetics and cosmetic dentistry, fueled by an aging population and increasing awareness of oral health. Technological advancements, such as digital dentistry and CAD/CAM systems, are enhancing the efficiency and precision of dental lab services. Additionally, the rise in dental tourism and the expanding reach of dental services in emerging markets are further contributing to market growth. As consumer expectations for aesthetic dental solutions increase, dental laboratories are focusing on innovation and quality to meet the evolving needs of patients and practitioners.
The Dental Laboratories Market is significantly led by North America and Europe. North America, particularly the United States, dominates the market with its advanced dental infrastructure, widespread adoption of digital dentistry technologies, and high demand for cosmetic procedures. Europe follows closely, driven by robust healthcare systems, increasing awareness of dental health, and strong demand for aesthetic dental solutions in countries like Germany, France, and the UK. Key players such as Dentsply Sirona, Straumann AG, and Danaher Corporation are pivotal in driving innovation and maintaining competitive market positions across these regions.
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Technological advancements driving precision and efficiency.
Technological advancements are profoundly transforming the Dental Laboratories Market, particularly with the integration of CAD/CAM technology. For instance, the integration of CAD/CAM technology has revolutionized the industry by enabling faster, more accurate, and highly customized dental restorations. Computer-aided design and manufacturing have revolutionized the industry by enabling faster, more accurate, and highly customized dental restorations. This technology streamlines the production process, reducing the time required to deliver precise dental prosthetics. Additionally, the rise of 3D printing has opened up new possibilities for creating complex dental prosthetics and orthodontic appliances with unmatched precision and flexibility. The adoption of digital dentistry, including intraoral scanners and digital impressions, has further streamlined workflows and enhanced communication between dentists and dental laboratories, resulting in improved patient outcomes.
The aging global population is another key factor fueling the demand for dental laboratory services. As people age, they are more likely to require various dental treatments, including dentures, bridges, and implants. For instance, government health reports have highlighted the increasing need for dental prosthetics among older demographics. This demographic shift is accompanied by an increase in disposable income among older adults, which further drives the demand for dental services. The growing need for restorative and prosthetic dental solutions among the elderly is prompting dental laboratories to expand their offerings and focus on developing products that cater to this segment of the population.
The increasing demand for cosmetic dentistry is a significant driver in the Dental Laboratories Market. As consumers become more aware of the benefits of procedures such as veneers, dental implants, and teeth whitening, the desire for aesthetically pleasing dental restorations has grown. This shift in aesthetic preferences reflects a broader trend where individuals place a higher value on their appearance, driving the demand for high-quality, customized dental solutions. As a result, dental laboratories are continuously innovating to meet the growing expectations for cosmetic dental treatments, which are increasingly seen as an essential part of overall wellness and self-confidence.
Expanding access to dental care is significantly boosting the Dental Laboratories Market. Increased insurance coverage for dental services has made them more accessible to a broader population, encouraging more individuals to seek dental treatments. Additionally, government initiatives aimed at improving dental health infrastructure and programs have played a crucial role in enhancing access to care. Moreover, the trend towards increased specialization in dental laboratories is driving improvements in service quality and efficiency. Laboratories specializing in specific areas, such as orthodontics, prosthetics, and implant dentistry, can offer more tailored and advanced solutions, meeting the growing demand for specialized dental care with greater precision and expertise.
Sustainable practices and global competition.
Sustainability is becoming a key consideration in the Dental Laboratories Market, with a growing emphasis on eco-friendly materials and processes. For instance, dental laboratories are adopting sustainable materials that minimize environmental impact, reflecting a broader industry trend towards greener practices. Dental laboratories are adopting sustainable materials that minimize environmental impact, reflecting a broader industry trend towards greener practices. Additionally, there are ongoing efforts to improve recycling and waste management within laboratories, as the industry recognizes the importance of reducing its ecological footprint. This focus on sustainability is increasingly important to both consumers and industry stakeholders, who are demanding more responsible and environmentally conscious practices. Concurrently, the market is experiencing increased global competition and outsourcing. To remain competitive, many dental laboratories are outsourcing work to regions with lower labor costs, which can offer cost-effective solutions for producing dental prosthetics and appliances. However, this globalization also introduces competition from international players, driving laboratories to continuously innovate and improve their offerings to maintain market share.
The integration of dental laboratories with dental practices is another prominent trend shaping the market. Some dental practices are establishing in-house laboratories to improve efficiency, reduce turnaround times, and gain greater control over the production of dental restorations. This vertical integration allows practices to offer more seamless and comprehensive care, enhancing the patient experience. Additionally, dental laboratories are forming strategic partnerships with dental practices, creating synergies that benefit both parties. These partnerships enable laboratories to better understand the specific needs of dental practices and tailor their services accordingly. By working closely with dentists, laboratories can ensure that the dental restorations they produce meet the highest standards of quality and precision, ultimately leading to better patient outcomes and increased satisfaction. This trend towards integration and collaboration is helping to create more cohesive and efficient dental care ecosystems.
Regulatory compliance and economic factors.
Regulatory compliance and economic factors also pose substantial challenges for the Dental Laboratories Market. Laboratories must navigate a complex regulatory environment, adhering to stringent safety, quality, and patient privacy regulations. For instance, dental laboratories must navigate a complex regulatory environment, adhering to stringent safety, quality, and patient privacy regulations. These regulations can vary by region and are subject to frequent changes, making it difficult for businesses to stay compliant without incurring additional costs. Failure to comply can result in penalties or loss of certification, further impacting business operations. Economic factors, such as recessions and inflation, add another layer of complexity. Economic downturns often lead to a decrease in demand for dental services as patients postpone elective procedures, directly affecting the workload and revenue of dental laboratories. Additionally, rising costs of materials, labor, and energy due to inflation can squeeze profit margins, making it harder for laboratories to sustain their operations, especially in an environment where competitive pricing is already a challenge.
Supply chain disruptions and labor shortages are further complicating the landscape for dental laboratories. Material shortages, particularly of key resources like metals and ceramics, can disrupt production schedules, leading to delays and increased costs. These disruptions are often exacerbated by global logistics challenges, which can delay the delivery of essential materials and finished products. Ensuring a steady supply chain is crucial for maintaining operational efficiency and meeting customer expectations. At the same time, dental laboratories are grappling with labor shortages, particularly in finding skilled technicians who are proficient in the latest technologies. The competition for talent is fierce, not only within the dental industry but across other sectors as well, making it difficult for laboratories to attract and retain skilled workers. This shortage of qualified personnel can limit a laboratory’s ability to expand services or adopt new technologies, further hindering growth and innovation.
By equipment :.
The Dental Laboratories Market is segmented by equipment, including dental radiology equipment, dental lasers, systems and parts, laboratory machines, hygiene maintenance devices, and others. Dental radiology equipment, such as digital X-ray machines, is increasingly in demand due to the growing emphasis on accurate diagnostics. Dental lasers, known for their precision and efficiency, are also gaining popularity in various procedures, including soft tissue surgeries and cavity preparation. Systems and parts, which include essential components like CAD/CAM systems, play a crucial role in modern dental laboratories, enabling high precision and faster turnaround times. Laboratory machines, including milling units and 3D printers, are integral for creating dental prosthetics and restorations. Additionally, hygiene maintenance devices are critical for ensuring the sterility and cleanliness of the equipment used, directly impacting patient safety and treatment outcomes.
The market is also segmented by product, encompassing restorative, orthodontic, endodontic, implant, and oral care products. Restorative products, such as crowns, bridges, and dentures, represent a significant portion of the market, driven by the increasing prevalence of dental caries and the aging population. Orthodontic products, including braces and aligners, are in high demand due to the growing awareness and desire for aesthetically pleasing dental solutions. Endodontic products, vital for root canal treatments, are essential in preserving natural teeth and preventing extractions. Implant products, which include dental implants and abutments, are experiencing rapid growth as more patients seek long-term solutions for tooth replacement. Oral care products, covering a range of preventive and maintenance items, continue to see steady demand as consumers prioritize oral hygiene and preventive care. The diversity in product offerings allows dental laboratories to cater to various dental needs, enhancing patient satisfaction and driving market growth.
Based on Equipment:
Based on Product:
Based on the Geography:
North america.
North America holds a dominant position in the Dental Laboratories Market, accounting for approximately 40% of the global market share. This leadership is driven by the region’s advanced healthcare infrastructure, high adoption of cutting-edge dental technologies, and strong demand for cosmetic and restorative dental procedures. The United States, in particular, is a key market, with significant investments in dental research and development, widespread insurance coverage for dental services, and a growing aging population requiring dental care. Additionally, the presence of major dental equipment manufacturers and dental laboratories in North America further bolsters the region’s market position. The increasing focus on digital dentistry, including CAD/CAM systems and 3D printing, is also propelling market growth in this region.
Europe follows closely, holding around 30% of the global Dental Laboratories Market share. The region’s market is characterized by a strong emphasis on dental health, supported by well-established healthcare systems and a high level of public awareness about dental care. For instance, a survey by the European Federation of Dental Laboratory Owners revealed that a substantial number of dental laboratories in Europe have invested in digital workflow technologies. Countries like Germany, France, and the United Kingdom are at the forefront, driven by a robust demand for advanced dental restorations and cosmetic dentistry. The aging population in Europe, coupled with increasing disposable income, is further driving the demand for dental services and products. Additionally, Europe’s stringent regulatory framework ensures high standards of safety and quality in dental laboratory practices, which contributes to the growth and reliability of the market in this region. The ongoing trend toward digitalization and the adoption of innovative dental technologies are expected to sustain Europe’s position as a key player in the global Dental Laboratories Market.
Key player analysis.
The competitive landscape of the Dental Laboratories Market is characterized by the strong presence of leading players such as Dentsply Sirona, Straumann AG, Danaher Corporation, 3M, and Henry Schein, Inc. These companies are focused on expanding their product portfolios through innovation in digital dentistry technologies, such as CAD/CAM systems, 3D printing, and advanced dental materials. They are also investing heavily in research and development to enhance the precision and efficiency of dental restorations and orthodontic appliances. Strategic acquisitions and partnerships are common strategies employed by these market leaders to strengthen their global footprint and access new markets. Despite the dominance of these large companies, the market also includes smaller, specialized players who contribute to the diversity and innovation within the industry, particularly in niche areas like dental implants and aesthetic dentistry. The ongoing competition drives continuous improvement and technological advancement, benefiting the overall growth and evolution of the market.
The Dental Laboratories Market exhibits moderate to high market concentration, with several key players dominating a significant portion of the market. Companies such as Dentsply Sirona, Straumann AG, and Danaher Corporation hold substantial market shares due to their extensive product portfolios, strong brand recognition, and global distribution networks. These leaders are characterized by their focus on innovation, particularly in the integration of digital technologies like CAD/CAM and 3D printing, which enhance the precision and efficiency of dental restorations. The market also features a diverse range of smaller, specialized laboratories that contribute to the industry by focusing on niche segments, such as custom dental implants and cosmetic dentistry. Despite the presence of these smaller players, the competitive landscape is heavily influenced by the leading companies, which set the pace for technological advancements and industry standards. The market’s concentration is further shaped by strategic partnerships, mergers, and acquisitions, which allow dominant players to expand their reach and solidify their positions.
The research report offers an in-depth analysis based on Equipment , Product and Geography . It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
3. Executive Summary
4. Introduction
4.1. Overview
4.2. Key Industry Trends
5. Global Dental Laboratories Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
6. Market Breakup by Equipment
6.1. Dental Radiology Equipment
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Dental Lasers
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity
6.3. Systems and Parts
6.3.1. Market Trends
6.3.2. Market Forecast
6.3.3. Revenue Share
6.3.4. Revenue Growth Opportunity
6.4. Laboratory Machines
6.4.1. Market Trends
6.4.2. Market Forecast
6.4.3. Revenue Share
6.4.4. Revenue Growth Opportunity
6.5. Hygiene Maintenance Devices
6.5.1. Market Trends
6.5.2. Market Forecast
6.5.3. Revenue Share
6.5.4. Revenue Growth Opportunity
6.6. Others
6.6.1. Market Trends
6.6.2. Market Forecast
6.6.3. Revenue Share
6.6.4. Revenue Growth Opportunity
7. Market Breakup by Product
7.1. Restorative Products
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Orthodontic Products
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
7.3. Endodontic Products
7.3.1. Market Trends
7.3.2. Market Forecast
7.3.3. Revenue Share
7.3.4. Revenue Growth Opportunity
7.4. Implant Products
7.4.1. Market Trends
7.4.2. Market Forecast
7.4.3. Revenue Share
7.4.4. Revenue Growth Opportunity
7.5. Oral Care Products
7.5.1. Market Trends
7.5.2. Market Forecast
7.5.3. Revenue Share
7.5.4. Revenue Growth Opportunity
8. Market Breakup by Region
8.1. North America
8.1.1. United States
8.1.1.1. Market Trends
8.1.1.2. Market Forecast
8.1.2. Canada
8.1.2.1. Market Trends
8.1.2.2. Market Forecast
8.2. Asia-Pacific
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. South Korea
8.2.5. Australia
8.2.6. Indonesia
8.2.7. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Others
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Others
8.5. Middle East and Africa
8.5.1. Market Trends
8.5.2. Market Breakup by Country
8.5.3. Market Forecast
9. SWOT Analysis
9.1. Overview
9.2. Strengths
9.3. Weaknesses
9.4. Opportunities
9.5. Threats
10. Value Chain Analysis
11. Porters Five Forces Analysis
11.1. Overview
11.2. Bargaining Power of Buyers
11.3. Bargaining Power of Suppliers
11.4. Degree of Competition
11.5. Threat of New Entrants
11.6. Threat of Substitutes
12. Price Analysis
13. Competitive Landscape
13.1. Market Structure
13.2. Key Players
13.3. Profiles of Key Players
13.3.1. A-dec Inc.
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio
13.3.1.3. Financials
13.3.1.4. SWOT Analysis
13.3.2. Bego GmbH & Co. Kg
13.3.3. Champlain Dental Laboratory, Inc.
13.3.4. Danaher Corporation
13.3.5. Dentsply Sirona
13.3.6. Envista Holdings Corporation
13.3.7. GC Corporation
13.3.8. Henry Schein, Inc.
13.3.9. Ivoclar Vivadent AG
13.3.10. Knight Dental Design
13.3.11. Mitsui Chemicals, Inc.
13.3.12. National Dentex Corporation
13.3.13. Planmeca OY
13.3.14. Septodont Holding
13.3.15. Straumann AG
13.3.16. 3M Health Care
13.3.17. Ultradent Products, Inc.
13.3.18. Zimmer Biomet Holdings, Inc.
14. Research Methodology
Frequently Asked Questions:
The market growth is driven by the increasing demand for advanced dental prosthetics and cosmetic dentistry, fueled by an aging population and greater awareness of oral health. Technological advancements, such as digital dentistry and CAD/CAM systems, also contribute significantly to enhancing the efficiency and precision of dental lab services.
The key segments within the market include equipment such as dental radiology equipment, dental lasers, systems and parts, laboratory machines, hygiene maintenance devices, and others. By product, the market includes restorative products, orthodontic products, endodontic products, implant products, and oral care products.
Major players in the market include Dentsply Sirona, Straumann AG, Danaher Corporation, 3M, and Henry Schein, Inc., all of whom lead the market with innovative products and extensive global reach.
India electronic medical record (emr) market, laxatives market, therapeutic drug monitoring market, donor egg ivf market, india laxatives market, binder clip market, japan vitamins market, japan red biotechnology market, japan restorative dentistry market, middle east and africa laxatives market, japan sleep apnea device market, uk laxatives market, purchase options, request free sample.
Have a question?
Don’t settle for less – trust Mitul to help you find the best solution.
Call: +91 6232 49 3207
Report delivery within 24 to 48 hours
– What people say ?-
I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.
Jana Schmidt CEDAR CX Technologies
– Connect with us –
+91 6232 49 3207
24/7 Research Support
– Research Methodology –
Going beyond the basics: advanced techniques in research methodology
How Credence Research helps you
In-depth insights & niche market
10% Free customization
Deep specific intelligence
Don’t settle for less – trust Mitul to help you find the best solution.
How Credence Research helps you?
Ready to transform data into decisions.
Request Your Free Sample Report and Start Your Journey of Informed Choices
IMAGES
VIDEO
COMMENTS
An important aspect to any research project is the oral presentation of the experiment to other people. As with a research report, you want to tell the story of your experiment: why the experiment was done, how it was done, the results, interpretation of the results, and why the experiment matters.
Delivery. It is important to dress appropriately, stand up straight, and project your voice towards the back of the room. Practise using a microphone, or any other presentation aids, in advance. If you don't have your own presenting style, think of the style of inspirational scientific speakers you have seen and imitate it.
In the social and behavioral sciences, an oral presentation assignment involves an individual student or group of students verbally addressing an audience on a specific research-based topic, often utilizing slides to help audience members understand and retain what they both see and hear. The purpose is to inform, report, and explain the significance of research findings, and your critical ...
Oral Presentations Purpose. An Oral Research Presentation is meant to showcase your research findings. A successful oral research presentation should: communicate the importance of your research; clearly state your findings and the analysis of those findings; prompt discussion between researcher and audience. Below you will find information on ...
7. Use your conclusion to convey gratitude and repeat your main point. Throughout your report, you'll address specific supporting material that will culminate in a convincing presentation of your main points. As you develop the conclusion, be sure to explicitly restate your main points.
Oral Presentation Structure. Like scientific papers, oral presentations at a conference or internal seminar are for sharing your research work with other scientists. They, too, must convince the ...
Note that an oral presentation is different from a written prese ntation. The oral presentation is like the Abstract, concise and to the point. The written paper can be as long, and detailed as necessary to fully explore the subject. Guidelines for Oral Presentation of Research - 2 C ONTENT ...
A good oral presentation is focused, concise, and interesting in order to trigger a discussion. Be well prepared; write a detailed outline. Introduce the subject. Talk about the sources and the method. Indicate if there are conflicting views about the subject (conflicting views trigger discussion). Make a statement about your new results (if ...
To assist the audience, a speaker could start by saying, "Today, I am going to cover three main points.". Then, state what each point is by using transitional words such as "First," "Second," and "Finally.". For research focused presentations, the structure following the overview is similar to an academic paper.
present your research question and why it matters; describe how you conducted your research, explain what you found out and what it means; and. conclude with a summary of your main points. Depending on your topic, you may need to provide background information so that the audience understands the significance of your inquiry.
Oral Presentations. Or. l Presen. ations1. PlanningOral presentations are one of the most common assignments i. college courses. Scholars, professionals, and students in all fields desire to disseminate the new knowledge they produce, and this is often accomplished by delivering oral presentations in class, at conferences, in public lectures, or i.
Make your writing interesting. Be sure to use better words than the standard and obvious "nice" or "big." Rather opt for words such as "gigantic" or "fantastic." 2. Add a little something to your oral report. Perhaps add pictures or make a life size model from the topic.
s interestGuide to Oral Presentation IntroductionsWhen giving an oral presentation, the most important p. rt of your entire presentation is the introduction. This is where you 1) capture your audience's interest, 2) give them a context for your work, 3) pose your central question, problem, or issue, and 4) off.
Oral Report Guidelines. The oral report should comprise the following: (1). Title transparency (2). Introduction (3). Materials and Methods (4). Results and Discussion (5). Conclusions. The purpose - that is, what needs to be communicated - of each section is identical to the written report.
Thesis is a type of research report. A thesis is a long-form research document that presents the findings and conclusions of an original research study conducted by a student as part of a graduate or postgraduate program. It is typically written by a student pursuing a higher degree, such as a Master's or Doctoral degree, although it can also ...
Research reporting is the oral or written presentation of the findings in such detail and form as to be readily understood and assessed by the society, economy or particularly by the researchers. As earlier said that it is the final stage of the research process and its purpose is to convey to interested persons the whole result of the study.
Oral Presentations. Online Only. Submit presentation materials to online event site by April 7. Create an oral presentation using standard presentation software. Create a voice-over for the presentation lasting 7 to 10 minutes; 12 minute maximum. Upload presentation with voice-over to YouTube as an unlisted video.
Images should be used to add depth to verbal content. For example, limit the number of bullet points on a slide to 4-6. Use accessible design. As with document design, be mindful of the readability of your visual. Also, think about what the type you choose conveys to your audience. Integrate visuals.
The time allotted for an oral report is 60 minutes. You should plan to talk for about 30-40 minutes with time for questions. Expect your professor to ask questions during the talk and after the report. The exam will end after an hour, so plan your time carefully and focus on the important concepts. An oral report is a form of show-and-tell.
In some classes, writing the research paper is only part of what is required. Your professor may also require you to give an oral presentation about your study. Here are some things to think about before you are scheduled to give your presentation. ... Oral Presentations. The Lab Report. University College Writing Centre. University of Toronto ...
An oral report is a presentation, usually done for a student's teacher and classmates, though it can also be done for a larger segment of the school community, for parents, or for a more open group, depending on the circumstances. For example, at a science fair, a student might present a report on his or her project periodically for the class ...
Introduction. In December 2021, the National Institutes of Health, National Institute of Dental and Craniofacial Research, released its landmark 790-page report, Oral Health in America: Advances and Challenges (1). This is the first publication of its kind since the agency's first Oral Health in America: A Report of the Surgeon General described the silent epidemic of oral diseases in 2000 (2).
Oral Health in America: Advances and Challenges is a culmination of two years of research and writing by over 400 contributors. As a follow up to the Surgeon General's Report on Oral Health in America, this report explores the nation's oral health over the last 20 years.
This research explored the possible target of cardamonin in treating OSCC via network pharmacological analysis. ... Scientific Reports - Mechanism of apoptosis in oral squamous cell carcinoma ...
Oral care products, covering a range of preventive and maintenance items, continue to see steady demand as consumers prioritize oral hygiene and preventive care. ... The research report offers an in-depth analysis based on Equipment, Product and Geography. It details leading market players, providing an overview of their business, product ...
Economic Research Report No. (ERR-337) 52 pp September 2024 Household Food Security in the United States in 2023. by Matthew P. Rabbitt, Madeline Reed-Jones, Laura J. Hales, and Michael P. Burke. An estimated 86.5 percent of U.S. households were food secure throughout the entire year in 2023, with access at all times to enough food for an ...